EC Pharmaceutical Strategy · June 24, 2026

Eudralex Volume 4: Reference and Retention Samples (revised, applicable as of 24 September 2026)

Revised Eudralex Volume 4 guidance on reference and retention samples for medicinal products enters into force.

High obligation Framework Pharmaceuticals EU-wide Pharmaceuticals

News announcement 24 June 2026 Eudralex Volume 4: Reference and Retention Samples (revised, applicable as of 24 September 2026) 1 min read

Dates and deadlines

Applies from

2026-09-24

Regulatory Deadline

September 24, 2026

Read the official source ↗

Published by EC Pharmaceutical Strategy. HealthSignal links to the original document; the summary above is extracted from the source text.